| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tisagenlecleucel | b-lymphocyte antigen cd19 | biotech | NA | drugbank , DGIDB | Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Lymphoma Follicular[MeSHID:D008224] |
2.45 | approved,investigational | antibody |
| tisagenlecleucel | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Lymphoma Follicular[MeSHID:D008224] |
2.45 | approved | unknown |
| tisagenlecleucel | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Relapse[MeSHID:D012008] Neoplasm Metastasis[MeSHID:D009362] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Lymphoma Follicular[MeSHID:D008224] |
1.77 | approved | unknown |
| click here to return to the previous page | ||||||||